Status:
COMPLETED
Trachoma Elimination Follow-up
Lead Sponsor:
University of California, San Francisco
Conditions:
Trachoma
Chlamydia
Eligibility:
All Genders
1+ years
Phase:
PHASE4
Brief Summary
The WHO has initiated a program to eliminate blinding trachoma by the year 2020, in large part by mass oral azithromycin distributions. It is not clear how frequently or for how long these treatments ...
Detailed Description
40 villages in the Gurage Zone of Ethiopia were randomly assigned to biannual treatment, annual treatment, and a single treatment. Each treatment consisted of a single dose of oral azithromycin to the...
Eligibility Criteria
Inclusion
- Age 1 to 5 years old in a village in the Gurage zone with endemic trachoma
Exclusion
- Refusal of village chief (for village inclusion), or refusal of parent or guardian (for individual inclusion)
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2005
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT00221364
Start Date
March 1 2003
End Date
April 1 2005
Last Update
July 15 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ORBIS-Ethiopia
Addis Ababa, Ethiopia